Sona Nanotech Inc. (SONA.CN)
CAD 0.28
(-3.51%)
CAD 0.28
(-3.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.6 Million CAD | 2.67% |
| 2022 | -2.67 Million CAD | 74.12% |
| 2021 | -10.35 Million CAD | -65.62% |
| 2020 | -6.24 Million CAD | -327.5% |
| 2019 | -1.46 Million CAD | 71.45% |
| 2018 | -5.12 Million CAD | -1331.47% |
| 2017 | -357.72 Thousand CAD | 29.88% |
| 2016 | -510.14 Thousand CAD | 43.8% |
| 2015 | -907.74 Thousand CAD | -80.76% |
| 2014 | -502.17 Thousand CAD | 19.6% |
| 2013 | -624.61 Thousand CAD | 34.56% |
| 2012 | -954.54 Thousand CAD | -9.86% |
| 2011 | -868.84 Thousand CAD | -13.09% |
| 2010 | -768.25 Thousand CAD | 91.16% |
| 2009 | -8.69 Million CAD | -249.68% |
| 2008 | -2.48 Million CAD | -138.67% |
| 2007 | -1.04 Million CAD | -313.99% |
| 2006 | -251.51 Thousand CAD | -6998.98% |
| 2005 | -3543.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -708.64 Thousand CAD | 8.63% |
| 2024 Q2 | -778.86 Thousand CAD | -4.16% |
| 2024 Q1 | -747.76 Thousand CAD | 21.33% |
| 2023 Q2 | -503.32 Thousand CAD | -34.36% |
| 2023 Q1 | -374.61 Thousand CAD | -139.61% |
| 2023 FY | -2.83 Million CAD | -5.92% |
| 2023 Q4 | -950.53 Thousand CAD | -10.74% |
| 2023 Q3 | -858.35 Thousand CAD | -70.54% |
| 2022 Q4 | 945.84 Thousand CAD | 220.47% |
| 2022 FY | -2.67 Million CAD | 74.12% |
| 2022 Q1 | -1.51 Million CAD | -10.41% |
| 2022 Q2 | -1.32 Million CAD | 12.16% |
| 2022 Q3 | -785.16 Thousand CAD | 40.86% |
| 2021 Q1 | -3.73 Million CAD | -8.12% |
| 2021 Q2 | -3.14 Million CAD | 15.73% |
| 2021 Q3 | -2.15 Million CAD | 31.39% |
| 2021 FY | -10.35 Million CAD | -65.62% |
| 2021 Q4 | -1.36 Million CAD | 36.53% |
| 2020 Q3 | -1.72 Million CAD | -225.81% |
| 2020 Q4 | -3.45 Million CAD | -100.33% |
| 2020 Q2 | -528.65 Thousand CAD | -71.91% |
| 2020 Q1 | -307.52 Thousand CAD | 29.15% |
| 2020 FY | -6.24 Million CAD | -327.5% |
| 2019 Q2 | -469.17 Thousand CAD | -29.68% |
| 2019 FY | -1.46 Million CAD | 71.45% |
| 2019 Q1 | -361.79 Thousand CAD | 92.48% |
| 2019 Q3 | -465.85 Thousand CAD | 0.71% |
| 2019 Q4 | -434.05 Thousand CAD | 6.83% |
| 2018 Q3 | -145.75 Thousand CAD | 4.5% |
| 2018 Q1 | -121.19 Thousand CAD | -46.23% |
| 2018 FY | -5.12 Million CAD | -1331.47% |
| 2018 Q4 | -4.8 Million CAD | -3198.71% |
| 2018 Q2 | -152.62 Thousand CAD | -25.93% |
| 2017 Q2 | -85.52 Thousand CAD | 14.37% |
| 2017 FY | -357.72 Thousand CAD | 29.88% |
| 2017 Q4 | -82.88 Thousand CAD | 6.5% |
| 2017 Q3 | -88.64 Thousand CAD | -3.64% |
| 2017 Q1 | -99.88 Thousand CAD | 31.77% |
| 2016 Q2 | -121.56 Thousand CAD | 7.05% |
| 2016 FY | -510.14 Thousand CAD | 43.8% |
| 2016 Q3 | -111.4 Thousand CAD | 8.36% |
| 2016 Q4 | -146.39 Thousand CAD | -31.41% |
| 2016 Q1 | -130.78 Thousand CAD | 73.4% |
| 2015 Q3 | -144.97 Thousand CAD | -1.06% |
| 2015 Q2 | -143.45 Thousand CAD | -12.44% |
| 2015 Q1 | -127.57 Thousand CAD | 15.96% |
| 2015 FY | -907.74 Thousand CAD | -80.76% |
| 2015 Q4 | -491.73 Thousand CAD | -239.19% |
| 2014 Q4 | -151.8 Thousand CAD | -28.22% |
| 2014 Q3 | -118.39 Thousand CAD | 4.3% |
| 2014 Q2 | -123.7 Thousand CAD | 9.88% |
| 2014 FY | -502.17 Thousand CAD | 19.6% |
| 2014 Q1 | -137.27 Thousand CAD | -2.79% |
| 2013 Q3 | -164.54 Thousand CAD | 1.96% |
| 2013 FY | -624.61 Thousand CAD | 34.56% |
| 2013 Q2 | -167.83 Thousand CAD | -5.76% |
| 2013 Q4 | -133.54 Thousand CAD | 18.84% |
| 2013 Q1 | -158.69 Thousand CAD | -103.76% |
| 2012 Q1 | -4.7 Million CAD | -1965.82% |
| 2012 FY | -954.54 Thousand CAD | -9.86% |
| 2012 Q4 | 4.21 Million CAD | 2605.96% |
| 2012 Q3 | -168.36 Thousand CAD | 54.1% |
| 2012 Q2 | -366.83 Thousand CAD | 92.19% |
| 2011 FY | -868.84 Thousand CAD | -13.09% |
| 2011 Q2 | -212.54 Thousand CAD | -2.88% |
| 2011 Q1 | -206.59 Thousand CAD | -13.46% |
| 2011 Q3 | -222.19 Thousand CAD | -4.54% |
| 2011 Q4 | -227.51 Thousand CAD | -2.39% |
| 2010 Q2 | -211.86 Thousand CAD | -1.63% |
| 2010 Q1 | -208.48 Thousand CAD | 97.42% |
| 2010 Q4 | -182.08 Thousand CAD | -9.81% |
| 2010 Q3 | -165.82 Thousand CAD | 21.73% |
| 2010 FY | -768.25 Thousand CAD | 91.16% |
| 2009 Q1 | -227.35 Thousand CAD | 63.34% |
| 2009 FY | -8.69 Million CAD | -249.68% |
| 2009 Q2 | -222.14 Thousand CAD | 2.29% |
| 2009 Q4 | -8.07 Million CAD | -4815.73% |
| 2009 Q3 | -164.29 Thousand CAD | 26.04% |
| 2008 Q2 | -1.26 Million CAD | -952.52% |
| 2008 Q4 | -620.11 Thousand CAD | -27.8% |
| 2008 Q3 | -485.22 Thousand CAD | 61.5% |
| 2008 FY | -2.48 Million CAD | -138.67% |
| 2008 Q1 | -119.74 Thousand CAD | 73.53% |
| 2007 Q4 | -452.4 Thousand CAD | -90.72% |
| 2007 Q3 | -237.21 Thousand CAD | -4.65% |
| 2007 Q2 | -226.66 Thousand CAD | -81.36% |
| 2007 Q1 | -124.97 Thousand CAD | -17.37% |
| 2007 FY | -1.04 Million CAD | -313.99% |
| 2006 FY | -251.51 Thousand CAD | -6998.98% |
| 2006 Q2 | -93.35 Thousand CAD | -217009.3% |
| 2006 Q4 | -106.47 Thousand CAD | -104.6% |
| 2006 Q3 | -52.04 Thousand CAD | 44.25% |
| 2006 Q1 | -43.00 CAD | 0.0% |
| 2005 FY | -3543.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioMark Diagnostics Inc. | -1.31 Million CAD | -98.147% |
| Izotropic Corporation | -1.56 Million CAD | -66.44% |